Page last updated: 2024-08-23

lovastatin and Drug Withdrawal Symptoms

lovastatin has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böhm, M; Hamm, CW; Heeschen, C; Laufs, U; Snapinn, S; White, HD	1
Bixler, EO; Kales, A; Manfredi, RL; Tyson, KL; Vgontzas, AN	1

Trials

1 trial(s) available for lovastatin and Drug Withdrawal Symptoms

Article	Year
Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:6 Topics: Adult; Female; Humans; Lovastatin; Male; Pravastatin; Sleep; Sleep Stages; Substance Withdrawal Syndrome	1991

Other Studies

1 other study(ies) available for lovastatin and Drug Withdrawal Symptoms

Article	Year
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation, 2002, Mar-26, Volume: 105, Issue:12 Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States	2002

Article

Year

Withdrawal of statins increases event rates in patients with acute coronary syndromes.

Circulation, 2002, Mar-26, Volume: 105, Issue:12

Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States

2002